AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 162 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $16,323,000 | -12.7% | 552,400 | +40.4% | 0.02% | -13.0% |
| Q1 2019 | $18,691,000 | +34.0% | 393,500 | +1.8% | 0.02% | +21.1% |
| Q4 2018 | $13,953,000 | -39.7% | 386,500 | +2.8% | 0.02% | -26.9% |
| Q3 2018 | $23,130,000 | +0.3% | 375,800 | +10.1% | 0.03% | +4.0% |
| Q2 2018 | $23,055,000 | +32.6% | 341,300 | +6.5% | 0.02% | +25.0% |
| Q1 2018 | $17,387,000 | +11.3% | 320,500 | +22.6% | 0.02% | +11.1% |
| Q4 2017 | $15,625,000 | +1186.0% | 261,500 | +946.0% | 0.02% | +800.0% |
| Q3 2017 | $1,215,000 | +84.9% | 25,000 | +100.0% | 0.00% | +100.0% |
| Q2 2017 | $657,000 | +51.0% | 12,500 | +8.7% | 0.00% | 0.0% |
| Q4 2016 | $435,000 | -37.7% | 11,500 | -37.8% | 0.00% | 0.0% |
| Q3 2016 | $698,000 | -13.0% | 18,500 | -32.7% | 0.00% | 0.0% |
| Q4 2014 | $802,000 | – | 27,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |